Transl. Lung Cancer Res. .2015 .. , 4(327) : .
Siegel R.,Ma J.,Zou Z.,Jemal A.,Clin A. .2014 .. , 64(9) : .
Min Z.,Am Surg. Oncol. Clin. N. .2016 .Classification and pathology of lung cancer,. , 25(447) : .
W. D. Travis M. B.,Beasley M. B. .2015 .The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. , 10(1243) : .
Am. Coll. Cardiol. .2015 .. , 66(1160) : .
Liu R.,Xu K. P.,Tan G. S. .2015 .Cyclooxygenase-2 inhibitors in lung cancer treatment: bench to bed, Eur. , 769(127) : .
P. Wu T. E.,Nielsen M. H.,Clausen M. H. .2015 .FDA-approved small-molecule kinase inhibitors. Trends Pharmacol Sci., 36(422) : .
Abd E. H. S. R.,Lasheen D. S.,Hassan M. A.,Abouzid K. A. M. .2016 .pyrimidine-based compounds as dual EGFR/HER-2 inhibitors, Arch. Design and synthesis of 4-anilinothieno[2, 349(827) : 3.
Ding H. G.,Cai Z. Q.,Hou L.,Hu Z. Q.,Jin Z. S.,Xu D.,Cao H.,M. M. Meng Y. H.,Xie D. Q.,Zheng D. Q. .2019 .Synthesis and evaluation of some novel 6-substituted quinazoline derivatives as antitumor agents. J. Chem. Soc. Pak., 41(186) : .
Hutson T. E.,Sternberg C. N. .2008 .Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma, Expert. , 17(253) : .
Friboulet N.,Li R.,Katayama C. C.,Lee J. F.,Gainorand A. S.,Crystal A. S. .2014 .The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell Lung cancer, Can. , 4(662) : .
Kim D. W.,Tiseo M.,Ahn M. J.,Reckamp K. L.,Hansenand K. H.,Kim S. W. .2017 .Brigatinib in patients with crizotinib-refractory anaplastic lymphoma kinase-positive non-Small-cell lung cancer: a randomized, multicenter phase II trial. , 35(2490) : .
M. Maemondo A.,Inoue K.,Kobayashi S.,Sugawara S.,Oizumi H.,Isobe H.,Med N. Engl. J. .2010 .Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. , 362(2380) : .
M. D. Marquez S.,Popat S. .2015 .Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for the treatment of advanced non-small-cell lung cancer, Future Oncol. , 11(2525) : .
J. C. Chuang A. A.,Salahudeen H. A.,Wakelee H. A. .2016 .Rociletinib, a third generation EGFR tyrosine kinase inhibitor: current data and future directions, Expert. , 17(989) : .
J. F. Sheng Z. H.,Liu M.,Yan X. J.,Zhang D. J.,Wang J.,Xu E. S.,Zhang E. S. .2017 .Biomass-involved synthesis of n-substituted benzofuro[2,3-d]pyrimidine-4-amines and biological evaluation as novel EGFR tyrosine kinase inhibitors. Org. Biomol. Chem, 15(4971) : .
J. T. Shi Y. L.,Gong J.,Li Y.,Wang Y.,Chen S.,Ding S.,- S. .2019 .Structure and Biological Activity of 2-[2-(4-fluorobenzylidene)hydrazinyl]-4-(1-met hyl. Chinese J. Struct. Chem, 38(9) : 2.
Liu R.,Wu X.,Dual AO .2015 .EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry, Med. Basic. Res., 21(15) : .